| Azithromycin alters macrophage phenotype BS Murphy, V Sundareshan, TJ Cory, D Hayes Jr, MI Anstead, DJ Feola Journal of Antimicrobial Chemotherapy 61 (3), 554-560, 2008 | 228 | 2008 |
| Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ... Science translational medicine 13 (620), eabh0272, 2021 | 146 | 2021 |
| Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-κB signaling pathways D Haydar, TJ Cory, SE Birket, BS Murphy, KR Pennypacker, AP Sinai, ... The Journal of Immunology 203 (4), 1021-1030, 2019 | 103 | 2019 |
| cBAF complex components and MYC cooperate early in CD8+ T cell fate A Guo, H Huang, Z Zhu, MJ Chen, H Shi, S Yuan, P Sharma, JP Connelly, ... Nature 607 (7917), 135-141, 2022 | 76 | 2022 |
| Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery D Haydar, H Houke, J Chiang, Z Yi, Z Odé, K Caldwell, X Zhu, KS Mercer, ... Neuro-oncology 23 (6), 999-1011, 2021 | 75 | 2021 |
| RASA2 ablation in T cells boosts antigen sensitivity and long-term function J Carnevale, E Shifrut, N Kale, WA Nyberg, F Blaeschke, YY Chen, Z Li, ... Nature 609 (7925), 174-182, 2022 | 70 | 2022 |
| Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight CA Land, PR Musich, D Haydar, G Krenciute, Q Xie Journal of translational medicine 18, 1-13, 2020 | 69 | 2020 |
| Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: potential therapeutic targets in ischemic heart disease A Al-Darraji, D Haydar, L Chelvarajan, H Tripathi, B Levitan, E Gao, ... PloS one 13 (7), e0200474, 2018 | 51 | 2018 |
| Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19 VJ Venditto, D Haydar, A Abdel-Latif, JC Gensel, MI Anstead, MG Pitts, ... Frontiers in immunology 12, 574425, 2021 | 47 | 2021 |
| Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR. CD28ζ T cells P Nguyen, E Okeke, M Clay, D Haydar, J Justice, C O’Reilly, ... Molecular Therapy-Oncolytics 18, 202-214, 2020 | 45 | 2020 |
| Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, C Brown, D Haydar, ... Cell reports 37 (2), 2021 | 17 | 2021 |
| Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction A Al-Darraji, RR Donahue, H Tripathi, H Peng, BM Levitan, L Chelvarajan, ... Scientific reports 10 (1), 16596, 2020 | 15 | 2020 |
| Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity. Sci. Transl. Med. 13, eabh0272 B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ... | 11 | 2021 |
| Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia D Haydar, R Gonzalez, BA Garvy, S Garneau-Tsodikova, NT Chandrika, ... Immunobiology 226 (1), 152034, 2021 | 7 | 2021 |
| T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges D Haydar, J Ibañez-Vega, G Krenciute Frontiers in Oncology 11, 4450, 2021 | 6 | 2021 |
| De novo DNA methylation programs regulate CAR T-cell exhaustion CC Zebley, CT Petersen, B Prinzing, M Bell, Y Fan, JC Crawford, H Houke, ... The Journal of Immunology 204 (1_Supplement), 246.5-246.5, 2020 | 5 | 2020 |
| Various modifications of condom balloon tamponade and their method, efficacy, outcomes in management of atonic postpartum hemorrhage in tertiary care centre-a observational study Y Dalia, M Agrawal, A Sharma JMSCR 6 (5), 482-9, 2018 | 5 | 2018 |
| Establishing Immunocompetent Leukemia Models to Investigate the Impact of CAR T Cells on the Immune Microenvironment and Bone Marrow Niche SE Moore, JT Zoine, JC Crawford, D Langfitt, JM Barajas, S Abdelhamed, ... Blood 140 (Supplement 1), 7376-7377, 2022 | 1 | 2022 |
| Immune competent pediatric sarcoma models for the preclinical evaluation of B7-H3-CAR T-Cell therapy KJ Caldwell, P Nguyen, A Beckett, D Haydar, Z Yi, G Krenciute, J Yustein, ... MOLECULAR THERAPY 29 (4), 326-326, 2021 | 1 | 2021 |
| IL-12 signaling promotes TET2-mediated DNA demethylation during CD8 T cell effector differentiation CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, D Haydar, T Harris, ... bioRxiv, 2020.11. 02.365148, 2020 | 1 | 2020 |
Giedre KrenciuteSt Jude Children's Research HospitalVerified email at stjude.org
